Abstract:Abstract Study Objective Cannabidiol (CBD) is increasingly used as a health supplement, though few human studies have shown benefits. The primary objective of this study was to evaluate the effects of an oral CBD-Terpene formulation on sleep physiology in insomniacs. Methods In this pilot study, six participants with insomnia completed a placebo-controlled trial of an oral administration of CBD (300 mg) and terpenes (1 mg each of linalool, myrcene, phytol, limonene, α-terpinene, α-terpineol, α-pinene, and β-caryophyllene), administered daily for 28 days using a cross-over design. Importantly, the study medication was devoid of Δ 9 -Tetrahydrocannabinol (Δ 9 -THC). The primary outcome measure was the percentage of time spent in slow wave sleep (SWS) and rapid eye movement (REM) sleep stages, as as measured by a wrist-worn sleep-tracking device. Results This CBD-terpene regimen increased both the percentage of time (11.9 ± 1.9%; 95% CI, 8.0 to 15.8%; P < 0.0001) and the absolute time (51.8 ± 8.9 min/night; 95% CI, 34.3 to 69.3; P < 0.0001) participants spent in SWS and REM sleep. This treatment had no effect on total sleep time (TST) and no adverse events were reported. Conclusion These results, if confirmed in larger clinical trials, suggest that select CBD-terpene ratios that increase SWS + REM (restorative) sleep have the potential to provide a safe and efficacious alternative to commonly prescribed sleep medications. Statement Of Significance Physicians are increasingly asked by their patients regarding the merits of using CBD for insomnia and other ailments, but lack any rigorous clinical research to support recommending its use. The current pilot study represents the first randomized, placebo-controlled, crossover study to investigate how an oral formulation of cannabidiol (CBD) and terpenes influences sleep physiology in participants who suffer from insomnia. In contrast to many prescription sleep medicines and over-the-counter sleep aids, the CBD-terpene formulation increased SWS and REM sleep, which are critical for the immune system, tissue regeneration, cognition and memory. These results, if confirmed in larger clinical trials, suggests that CBD might offer a promising alternative to other sleep medications and aids.

Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor

Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models

Chaihu-Longgu-Muli Decoction promotes sleep in mice with insomnia

A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats

Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, crossover study

Beta-Myrcene as a Sedative-Hypnotic Component from Lavender Essential Oil in DL-4-Chlorophenylalanine-Induced-Insomnia Mice

A Cannabidiol/Terpene Formulation That Increases Restorative Sleep in Insomniacs: A Double-Blind, Placebo-controlled, Randomized, Crossover Pilot Study

Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model

Ginsenoside Rg5/Rk1 ameliorated sleep <i>via</i> regulating the GABAergic/serotoninergic signaling pathway in a rodent model

Exploring the therapeutic potential of cannabidiol for sleep deprivation-induced hyperalgesia

Effect of ZiyinYangxueAnshen Decoction on Sleep of Mice Models with Insomnia Induced by PCPA

In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists

Study of Rhizoma Coptidis alkaloids on promoting sleep in mice

Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Cannabinoids promote NREM sleep via inhibition of prefrontal cortico-hypothalamic projections

Exploring Biological Mechanisms and Therapeutic Potentials

Pharmacokinetics of Oral and Intravenous Cannabidiol and Its Antidepressant-Like Effects in Chronic Mild Stress Mouse Model.

Sedative-Hypnotic Effects of Deoxyschisandrin through Serotonergic and Gabaergic System in Mice

Systematic review/meta‐analysis on the role of CB1R regulation in sleep‐wake cycle in rats

Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides